On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...